“You want the truth; you can’t handle the truth”! I have been covering Fitbit (FIT) since January of 2016. I’ve found that most investors, institutional or otherwise, simply couldn’t handle the fact that Fitbit’s total addressable market (TAM) was far less than the company and investors had assumed. In my initial reporting and publication titled Fitbit’s Total Addressable Market Hype May…
Tags: FIT FitBitFitbit Retrenches: The Bottoming Phase For A Hardware Company
A financial market resource for the every-day investor and trader.
-
An Endless Bear and Suffering Bull
Seth Golden, , Research Reports, 0
I don’t know that there were many investors/traders who anticipated the route in markets this past week, but there...
-
Weekly State Of The Market: It’s A Bull Fight
Seth Golden, , Research Reports, 0
“The greatest enemy of a good plan is the dream of a perfect plan. Stick to the good plan.”...
-
Deep Dives Demand Devotion and Endurance
Seth Golden, , Research Reports, 4
Just one week ago, the S&P 500 finished higher for the week by 4.9%, which seems a lifetime ago...
-
Value Squeeze: J.P. Morgan Team
Seth Golden, , Research Reports, 0
US Equity Strategy Style Positioning, Value Squeeze, Winner Takes All Rising odds of a sharp Value squeeze in the...
-
Market Recovery Process Meets Resurgence Fears
Seth Golden, , Research Reports, 0
After retreating some 4.7% in the previous week, the S&P 500 (SPX) took back some of the consolidation. For...
-
Will 2023 Deliver A New Uptrend?
Seth Golden, , Research Reports, 0
Last year proved a painful time to be an investor, and for the most part, it didn’t matter what...
-
Morgan Stanley 2023 Outlook
Seth Golden, , Research Reports, 0
Ahead of the holiday and turn of year period, Morgan Stanley publishes their outlook for 2023. The outlook is...
-
Target May Have Beaten Expectations, But Inventory Reductions Loom Large With Investors
Seth Golden, , Research Reports, 0
Back in March of 2017, I authored an article that focused on all that has been ailing Target Corp....
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00